Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;72(11):1891-1899.
doi: 10.1093/cid/ciaa801.

Risk Factors for Recurrent Staphylococcus aureus Bacteremia

Affiliations

Risk Factors for Recurrent Staphylococcus aureus Bacteremia

Seong-Ho Choi et al. Clin Infect Dis. .

Abstract

Background: To understand the clinical, bacterial, and host characteristics associated with recurrent Staphylococcus aureus bacteremia (R-SAB), patients with R-SAB were compared to contemporaneous patients with a single episode of SAB (S-SAB).

Methods: All SAB isolates underwent spa genotyping. All isolates from R-SAB patients underwent pulsed-field gel electrophoresis (PFGE). PFGE-indistinguishable pairs from 40 patients underwent whole genome sequencing (WGS). Acute phase plasma from R-SAB and S-SAB patients was matched 1:1 for age, race, sex, and bacterial genotype, and underwent cytokine quantification using 25-analyte multiplex bead array.

Results: R-SAB occurred in 69 (9.1%) of the 756 study patients. Of the 69 patients, 30 experienced relapse (43.5%) and 39 reinfection (56.5%). Age, race, hemodialysis dependence, presence of foreign body, methicillin-resistant Staphyloccus aureus, and persistent bacteremia were individually associated with likelihood of recurrence. Multivariate risk modeling revealed that black hemodialysis patients were nearly 2 times more likely (odds ratio [OR] = 9.652 [95% confidence interval [CI], 5.402-17.418]) than white hemodialysis patients (OR = 4.53 [95% CI, 1.696-10.879]) to experience R-SAB. WGS confirmed PFGE interpretations in all cases. Median RANTES (regulated on activation, normal T cell expressed and secreted) levels in acute phase plasma from the initial episode of SAB were higher in R-SAB than in matched S-SAB controls (P = .0053, false discovery rate < 0.10).

Conclusion: This study identified several risk factors for R-SAB. The largest risk for R-SAB is among black hemodialysis patients. Higher RANTES levels in R-SAB compared to matched controls warrants further study.

Keywords: Staphylococcus aureus; bacteremia; health disparity; recurrence; whole genome sequencing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow of classification of study patients based on PFGE and cutoff value of the time between the first episode of SAB) and the subsequent episode of recurrent SAB (ΔT). Abbreviations: PFGE, pulsed-field gel electrophoresis; SAB, S. aureus bacteremia.
Figure 2.
Figure 2.
Distribution of the number of SNPs for isolate pairs between individuals with fewer than 200 SNPs (between) compared to pairs of isolates from the same individual with a PFGE match (within). Supplementary Figure 5 indicates that the isolate pairs between individuals are a visual PFGE match. Abbreviations: PFGE, pulsed-field gel electrophoresis; SNP, single-nucleotide polymorphism.
Figure 3.
Figure 3.
A, Comparison of baseline plasma RANTES level between patients with recurrent SAB) and age/sex/race/genotype-matched patients with a resolving single episode of SAB. B, Difference in RANTES values between recurrent SAB and their matched single SAB. We also examined a more conservative set of fewer than 100 SNPs. Here the median for the “across individual” set was 74 and still significantly different from the “same individual” pairs (P < .0001). Abbreviations: RANTES, regulated on activation, normal T cell expressed and secreted; SAB, Staphylococcus aureus bacteremia; SNP, single-nucleotide polymorphism.

References

    1. Fowler VGJ, Holland TL. Clinical approach to Staphylococcus aureus bacteremia in adults. In: Lowy FD, ed. UpToDate. Waltham, MA: UpToDate Inc.
    1. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163:2066–72. - PubMed
    1. Hawkins C, Huang J, Jin N, Noskin GA, Zembower TR, Bolon M. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Arch Intern Med 2007; 167:1861–7. - PubMed
    1. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28:603–61. - PMC - PubMed
    1. Albertson J, McDanel JS, Carnahan R, et al. Determination of risk factors for recurrent methicillin-resistant Staphylococcus aureus bacteremia in a Veterans Affairs healthcare system population. Infect Control Hosp Epidemiol 2015; 36:543–9. - PubMed

Publication types